Roshan Naik, PhD 🇮🇳 Scientist, BFI BIOME Fellow

@BFI_Impact @biolockey @_sandeepnailwal @CryptoRelief_ @CentellaScient1 @tweetcaremother @intignusbiotech That is a very useful insight.

For many health innovators, the instinct is to focus on the science, the technology, the mechanism , the clinical promise and regulatory approvals. But in the European healthcare market , success is determined by something less obvious. It depends on how value is created and paid for. At the recent BFI VK Connect Masterclass , delivered by Josep Ballesté Alabart, Vice President, The Swala Institute, one key idea stood out. Many innovators see regulatory approval as the finish line. In Europe, it is only the beginning . The key questions beyond regulation are: •⁠ ⁠Is the clinical benefit proven against the current standard of care? •⁠ ⁠Does it create meaningful value for patients and the system? •⁠ ⁠Can the system afford it at scale? Europe also is not a single healthcare market. While regulation is harmonized , reimbursement and procurement are decided country wise . Launch strategy based on the chosen geography determines pricing, adoption speed, and long-term revenue potential. The future of any health technology in the EU market is decided by one defining question.

🗓️Save the date: June 11-12, 2026 👉hello-tomorrow.org/global-summit/… #DeepTechPioneers #HelloTomorrow2026

Thrilled to announce that we’ve been named one of @hellotmrc’s Deep Tech Pioneers! 🎉 Join us at the Hello Tomorrow Summit in Amsterdam to connect and discover the most game-changing deep tech startups in the world.

@ashwinielephant @TiEPune @flytbase @n_karkare @JRTanna @aparanjape problem resolved by @TiEPune Team. Thank you

@NeuuRos @TiEPune @flytbase @n_karkare @JRTanna @aparanjape Will alert the website team at @TiEPune. Apologies for the inconvenience

How do you build for scale? Think teams, GTM, pricing—and the right guidance. @flytbase founder Nitin Gupta shares how #TiEPuneNurture changed his journey! Applications for #Nurture14 are open! 🔗tinyurl.com/nurture14 @ashwinielephant @n_karkare @JRTanna @aparanjape

@snehamordani periodic use of antibiotic susceptibility using random isolates from poultry, litter to map antimicrobial surveillance.

@snehamordani antibiotics in poultry is a common practice even in developed countries. However, it is important to avoid using antibiotics that are critical for human health (eg. colistin). FSSAI to set guidelines on antibiotic residue in chicken meat, periodic use of antibiotic susceptibility

In more bad news for Chicken lovers, here is what has been found by the Bureau of Investigative Journalism Venky’s, a major poultry producer in India, found marketing antibiotics for growth promotion and preventative use on farms. The company sells products containing vital antibiotics classified by WHO as crucial for human health, contributing to drug-resistant infections. Controversial Practices: - Antibiotics used for growth promotion & preventative used are banned in EU & US due to their impact on antibiotic effectiveness in humans. - Previous use of colistin as a growth promoter led to government ban after criticism. Product Listings: - Venky’s markets medicated poultry feeds containing antibiotics like tylosin and amoxicillin for growth promotion. - Products like Tylomix and Amo-premix listed on their website contain antibiotics vital for human medicine. Concerns Raised: - Unmonitored antibiotic use in poultry farming termed “a recipe for disaster” by experts. - Overuse of antibiotics contributing to the spread of drug-resistant foodborne diseases globally. Global Impact of Antimicrobial Resistance: - Landmark study in 2019 estimated over 1.27 million deaths due to AMR-related infections, surpassing HIV/AIDS and malaria deaths. - Antimicrobial-resistant infections implicated in nearly 5 million deaths globally. - Urgent need to address unregulated antibiotic use in poultry farming to preserve antibiotic effectiveness and minimize antimicrobial resistance risks.

🔴higher leukocytes(3lakh/ml) as shown in the second image. 🔴 Furthermore, Blood and milk was collected and we confirmed bacterial infection. 🔴Antibiotic susceptibility results with the PAS kit provided to local Veterinarian

#mastitis #antimicrobialresistance #merify #PASkit #dairy #cattle #OneHealth 🔴We visited Vishant, a Dairy farmer in Guleli village, Sattari taluka, Goa who has observed his daily milk production for this cow reduce from 15L/day to 3L/day. Apparently, cattle seemed normal..

@airtelindia there is no airtel network in top cola, borim,ponda, goa since last 15 days. There is no possibility to diagnose problem through airtel thanks app as no internet. Kindly help us

Need of the hour

#cranberryjuice don't treat #urinarytractinfections

Rapid antimicrobial susceptibility data are critical to guide appropriate antibiotic prescribing as well as to inform interventions to prevent repeated UTI infections #urinarytractinfections #antimicrobialresistance #diagopreutic

Dog UTI prevention tips 1. make sure your dog is drinking enough water. 2. keep your dogs well groomed especially around genital areas 3. Encourage potty breaks #urinarytractinfection #pethealth #diagopreutic

#TechnologyForLicensing: CCAMP in collaboration with the Institute for Plasma Research, Gandhinagar, has designed a novel air purification plus decontamination technology that overcomes the limitations of existing filtration-based air purification techniques The solution, called Plasma Clean is capable of both -Neutralizing pathogens -Trapping/removing PM 2.5 & PM 10 particles rendering improved ambient air quality Plus points - 📌It leads to quicker disinfection of air and can cover the entire range of usual pollutants, pathogens, SPM and VoCs This device can be customized as stand-alone as well as in conjunction with existing filtration devices and AHU systems Device is scalable as the cartridge is modular and can be installed in specific numbers customized to suit the application Disinfection capability has been validated on the ESKAPE range of bacterial pathogens, fungal pathogens & viral organisms by an independent NABL-accredited lab #IP Status: Indian Provisional Application filed (Sept 2023) We are seeking interest in licensing/Co-development from companies and industry partners with global outreach To learn more about this #tech, please reach out to the CCAMP Office of Technology Transfer (#OTT): Email- ott[at]ccamp.res. in / Call- 080 6718 5322 Supported by @PrinSciAdvOff & Pratiksha Trust @kris_sg @DBTIndia @BIRAC_2012 @Taslimarif

@INDOGSTC thank you

@NeuuRos There was a technical glitch. The portal is working again.

@INDOGSTC is the SMALL IMMEDIATE NEED GRANTS(SING) discontinued? i am unable to apply. It says campaign ended. I met representatives at BioIndia conference, they said can apply throughout the year can apply.

@minmsme @MeNarayanRane @bpsvermabjp @PIB_India @scsthub @CGTMSEOfficial @nimsmeeconnect @MSDESkillIndia @NSICLTD @IndianCoir @kvicindia indeed an inspiring story

Read the inspiring success story of Mr. Sumit Prabhakarrao Raut. Build the enterprise of your dreams with @minmsme